MBF-Protivovirus

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMBF-Protivovirus
Drug Alias Namebroad spectrum therapeutic (Medbiopharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedBioPharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedBioPharm Ltd
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A